Another change at the top: Marijuana MSO MedMen taps Ellen Deutsch as CEO

July 8, 2023 · MJ Biz Daily

California-based marijuana multistate operator MedMen Enterprises hired Ellen Deutsch as CEO and Amit Pandey as chief financial officer.

One of the few women installed in the top role at a marijuana MSO, Deutsch “succeeds interim CEO Edward Record” effective immediately, according to a news release.

Deutsch is at least the fifth CEO to lead MedMen since January 2020.

“Ellen’s leadership and strong operational experience in the public cannabis sector will prove invaluable as we complete our restructuring plan and transition into a new phase of growth for the company,” MedMen Chair Michael Serruya said in a statement.

Serruya served as interim CEO from November 2021 to April 2022, when Record took the top post.

Record was not given an “interim” tag at the time of his hire. He will retain his board seat.

Deutsch most recently served as senior vice president of market development and shared services at Chicago-based MSO Acreage Holdings.

She also served as executive vice president/chief operating officer at Florida-headquartered, vertically integrated Stem Holdings.

Pandey will take over the finance role July 24, according to the release.

He replaces Ana Bowman, who resigned June 29, less than 18 months after taking the job.

MedMen did not provide a reason for Bowman’s resignation in a release.

The C-suite additions complete the build-out of the new management team, MedMen said.

The executive shake-up comes amid significant changes at the company.

In February, the MSO hired ATB Capital Markets to potentially help the company divest assets in three states.

According to a release at the time, MedMen said restructuring efforts reduced payroll expenses by 34% and helped the company return to a positive adjusted earnings before interest, taxes, depreciation and amortization, a key financial metric of performance.

MedMen has faced a long list of challenges in the past year, ranging from offloading its Florida assets for $16 million less than the original offer to the failed sale of its New York assets to MSO Ascend Wellness.

In recent regulatory filings, MedMen has raised “substantial doubts” about its ability to meet financial obligations and has noted “its cash needs are significant and not achievable” with cash flow from operations. (Full Story)

In category:Business
Next Post

New York Cannabis Farmers Markets in Limbo

New York Gov. Kathy Hochul’s office appears to have put an indefinite hold on an idea floated in May by state regulators for marijuana farmers markets, a plan popular with growers because it would have provided a safety valve for hundreds…
Previous Post

Unpaid cannabis regulatory fees continue to climb in Canada

Unpaid regulatory fees owed by cannabis companies to Canada’s federal government jumped more than 200% from a year earlier, to almost 4 million Canadian dollars ($3.1 million) as of the end of March, MJBizDaily has learned. The overdue fees have grown every…
Random Post

Canadian cannabis firms increasingly flag rivals over alleged misdeeds

More Canadian cannabis operators than ever are lodging complaints against rival businesses over alleged transgressions or other concerns, a phenomenon being driven by intense competition and desperate companies looking for any edge they can get, according to experts. Last year,…
Random Post

FDA Releases Draft Guidance for Psychedelic Drugs Research

The U.S. Food and Drug Administration (FDA) on Monday released its Draft Guidance for research of psychedelic drugs. The guidance covers psilocybin, LSD, and substances such as MDMA. The guidance mirrors the good practices required by other drug and therapeutic companies, including…
Random Post

Washington Lawmakers Set To Enact Interstate Marijuana Sales Bill

Lawmakers in Washington State are on the cusp of passing legislation that would set the stage for licensed marijuana businesses to be able to engage in cross-border commerce with cannabis companies in other legal states. The state’s House of Representatives…
Random Post

Lawsuit challenges Virginia’s new hemp-product restrictions

Two hemp businesses and a consumer filed a lawsuit in Virginia federal court contending the state’s new restrictions on low-THC, hemp-derived products is causing financial harm to hemp companies and inhibiting interstate commerce. The lawsuit by hemp-product retailer Northern Virginia Hemp and…